New injection method tested for hard-to-treat blood cancer
NCT ID NCT04045795
Summary
This study tested whether a multiple myeloma drug called isatuximab could be given as a simple injection under the skin instead of through an IV. Researchers compared both methods in 56 patients whose cancer had returned or stopped responding to previous treatments. The main goals were to check if the injection method was safe, how the body processed the drug, and whether it worked as well as the IV method.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Site Number : 8400002
Duarte, California, 91010, United States
-
Gabrail Cancer Center Site Number : 8400001
Canton, Ohio, 44718, United States
-
Investigational Site Number : 0360001
Wollongong, New South Wales, 2500, Australia
-
Investigational Site Number : 0360002
Blacktown, New South Wales, 2148, Australia
-
Investigational Site Number : 0360003
Richmond, Victoria, 3121, Australia
-
Investigational Site Number : 0360004
Fitzroy, Victoria, 3065, Australia
-
Investigational Site Number : 0560001
Leuven, 3000, Belgium
-
Investigational Site Number : 2500001
Nantes, 44093, France
-
Investigational Site Number : 2500002
Toulouse, 31059, France
-
Investigational Site Number : 3920001
Shibuya-ku, Tokyo, 150-8935, Japan
-
Investigational Site Number : 3920002
Okayama, Okayama-ken, 701-1192, Japan
-
Investigational Site Number : 7240001
Badalona, Catalunya [Cataluña], 08916, Spain
-
Investigational Site Number : 7240002
Santander, Cantabria, 39008, Spain
-
~Banner MD Anderson Cancer Center Site Number : 8400005
Gilbert, Arizona, 85234, United States
Conditions
Explore the condition pages connected to this study.